医学临床研究
  2025年5月6日 星期二           首 页    |    期刊简介    |    编委会    |    投稿指南    |    期刊订阅    |    广告合作    |    留言板    |    联系我们    |    English
医学临床研究  2020, Vol. 37 Issue (10): 1552-1554    DOI: 10.3969/j.issn.1671-7171.2020.10.034
  论著 本期目录 | 过刊浏览 | 高级检索 |
血清HbA1c、sST2、NT-proBNP水平变化对急性冠脉综合征患者预后评估价值
王海波1, 陈入菲2
1.渭南市中心医院心血管内科,陕西 渭南 714000;
2.西北大学附属西安市第三医院心血管内科三病区,陕西 西安 710018
Prognostic Value of Serum HbA1c, sST2 and NT-proBNP Levels in Patients with Acute Coronary Syndrome
WANG Hai-bo, CHEN Ru-fei
Department of Cardiology, Weinan Central Hospital, Weinan 714000, Shaanxi, China
全文: PDF (0 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 【目的】 探讨糖化血红蛋白(HbA1c)、可溶性生长刺激表达基因2蛋白(sST2)、N氨基末端B型脑钠肽前体(NT-proBNP)与急性冠脉综合征(ACS)患者预后评价价值。【方法】 选取 2017年1月至2019年3月本院收治的70例ACS患者的临床资料,所有患者均于入院当日采血检测血清HbA1c、sST2、NT-proBNP水平。根据患者的病变程度分成单支病变组、双支病变组、三支病变组,比较三组血清HbA1c、sST2、NT-proBNP水平,观察三项血清指标与ACS病变程度的关系。根据患者预后情况分成预后良好组、预后不良组,比较两组血清HbA1c、sST2、NT-proBNP水平,绘制受试者工作特征曲线(ROC)分析各指标对不良预后的预测价值。【结果】 三支病变组血清HbA1c、sST2、NT-proBNP水平高于单支、双支病变组,且双支病变组各指标高于单支病变组,组间比较有统计学意义(P<0.05)。预后不良组血清HbA1c、sST2、NT-proBNP水平显著高于预后良好组,差异有统计学意义(P<0.05)。血清HbA1c、sST2、NT-proBNP预测ACS患者预后不良的曲线下面积分别为0.748、0.666、0.664。以HbA1c>5.675 mmol/L、sST2>24.195 ng/mL、NT-proBNP>666.725 ng/L为截断值,患者预后不良风险高。【结论】 随着ACS患者的病变程度越重,其血清HbA1c、sST2、NT-proBNP水平越高,且三者对患者不良预后具有一定预测价值。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
王海波
陈入菲
关键词 冠状动脉疾病急性病综合征利钠肽 脑/血液    
Abstract【Objective】 To investigate the prognostic value of glycosylated hemoglobin (HbAl C), soluble growth stimulating gene 2 protein (sST2), N-terminal pro brain natriuretic peptide (NT- proBNP) in patients with acute coronary syndrome (ACS). 【Methods】 The clinical data of 70 patients with ACS admitted to our hospital from January 2017 to March 2019 were selected. All patients were taken blood on the day of admission to detect the levels of serum HbA1c, sST2 and NT-proBNP. According to the severity of the disease, the patients were divided into single vessel disease group, double vessel disease group and three vessel disease group. The levels of serum HbA1c, sST2 and NT-proBNP in the three groups were compared, and the relationship between the three serum indexes and the severity of ACS was observed. According to the prognosis, the patients were divided into good prognosis group and poor prognosis group. The levels of serum HbA1c, sST2 and NT-proBNP were compared between the two groups, and the receiver operating characteristic curve (ROC) was drawn to analyze the predictive value of each index for poor prognosis.【Results】 The levels of HbA1c, sST2 and NT-proBNP in the three vessel disease group were higher than those in the single vessel disease group and the double vessel disease group, and the indexes in the double vessel disease group were higher than those in the single vessel disease group (P<0.05). The levels of HbA1c, sST2 and NT-proBNP in poor prognosis group were significantly higher than those in good prognosis group (P<0.05). The area under the curve of serum HbA1c, sST2 and NT-proBNP in predicting poor prognosis of ACS patients were 0.748, 0.666 and 0.664, respectively. Taking HbA1c>5.675 mmol/L, sST2 >24.195 ng/mL, NT-proBNP>666.725 ng/L as cut-off values, patients had a high risk of poor prognosis. 【Conclusion】 With the severity of ACS, serum HbA1c, sST2 and NT-proBNP levels are higher, and the three have a certain predictive value for the poor prognosis of patients.
Key wordsCoronary Artery Disease    Acute Disease    Syndrome    Natriuretic Peptide    Brain/BL
收稿日期: 2019-09-17     
PACS:  R543.31  
通讯作者: E-mail:whb2168870@163.com   
引用本文:   
王海波, 陈入菲. 血清HbA1c、sST2、NT-proBNP水平变化对急性冠脉综合征患者预后评估价值[J]. 医学临床研究, 2020, 37(10): 1552-1554.
WANG Hai-bo, CHEN Ru-fei. Prognostic Value of Serum HbA1c, sST2 and NT-proBNP Levels in Patients with Acute Coronary Syndrome. JOURNAL OF CLINICAL RESEARCH, 2020, 37(10): 1552-1554.
链接本文:  
http://journal07.magtech.org.cn/yxlcyj/CN/10.3969/j.issn.1671-7171.2020.10.034     或     http://journal07.magtech.org.cn/yxlcyj/CN/Y2020/V37/I10/1552
版权所有 © 2013 医学临床研究杂志社  湘ICP备13012052号-1
办公地址:湖南省长沙市芙蓉区新军路43号煤炭大院主办公楼6楼621、623、632、636室 邮编:410011 电话(传真):0731-84824007 E-mail:jcr_cs.hn@vip.163.com
技术支持:北京玛格泰克科技发展有限公司 技术支持:support@magtech.com.cn